NIPH Clinical Trials Search

Comparison of gastric and small-bowel transit time between lubiprostone and placebo in healthy volunteers: a double-blind, placebo-controlled study by capsule endoscopy

Basic Information

Recruitment status	Recruiting
Health condition(s) or Problem(s) studied	Healthy volunteers
Date of first enrollment	2014/01/06
Target sample size	20
Countries of recruitment	Japan
Study type	Interventional
Intervention(s)	The group who takes lubiprostone 24µg The group who takes Placebo

Outcome(s)

Primary Outcome	gastric and small-bowel transit time
Secondary Outcome	Endoscopic image

Key inclusion & exclusion criteria

Age minimum	20years-old
Age maximum	Not applicable
Gender	Male and Female
Include criteria	Patient who fills everything the following 1) Patient of 20 years or more 2) Patient who gives written informed consent
Exclude criteria	The patient who collides with either the following assumes that it dosen't put it in to the examination 1) Drug allergy 2) Subjects with malignancy 3) Others